Absci (ABSI) Competitors $3.68 -0.33 (-8.23%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$3.48 -0.20 (-5.43%) As of 10/10/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ABSI vs. VVX, LZ, RAMP, ALIT, FIVN, ACVA, OLO, FLYW, ASTH, and GDRXShould you be buying Absci stock or one of its competitors? The main competitors of Absci include V2X (VVX), LegalZoom.com (LZ), LiveRamp (RAMP), Alight (ALIT), Five9 (FIVN), ACV Auctions (ACVA), OLO (OLO), Flywire (FLYW), Astrana Health (ASTH), and GoodRx (GDRX). These companies are all part of the "business services" industry. Absci vs. Its Competitors V2X LegalZoom.com LiveRamp Alight Five9 ACV Auctions OLO Flywire Astrana Health GoodRx V2X (NYSE:VVX) and Absci (NASDAQ:ABSI) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, media sentiment, risk, profitability and institutional ownership. Do analysts prefer VVX or ABSI? V2X currently has a consensus price target of $62.60, indicating a potential upside of 12.23%. Absci has a consensus price target of $7.98, indicating a potential upside of 116.79%. Given Absci's stronger consensus rating and higher probable upside, analysts clearly believe Absci is more favorable than V2X.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score V2X 2 Sell rating(s) 2 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.45Absci 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.71 Does the media prefer VVX or ABSI? In the previous week, Absci had 4 more articles in the media than V2X. MarketBeat recorded 6 mentions for Absci and 2 mentions for V2X. V2X's average media sentiment score of 0.80 beat Absci's score of 0.47 indicating that V2X is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment V2X 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Absci 0 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders hold more shares of VVX or ABSI? 95.2% of V2X shares are owned by institutional investors. Comparatively, 52.1% of Absci shares are owned by institutional investors. 1.1% of V2X shares are owned by company insiders. Comparatively, 10.5% of Absci shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more risk and volatility, VVX or ABSI? V2X has a beta of 0.25, indicating that its stock price is 75% less volatile than the S&P 500. Comparatively, Absci has a beta of 2.06, indicating that its stock price is 106% more volatile than the S&P 500. Which has higher valuation & earnings, VVX or ABSI? V2X has higher revenue and earnings than Absci. Absci is trading at a lower price-to-earnings ratio than V2X, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioV2X$4.32B0.41$34.68M$2.2025.35Absci$4.53M121.46-$103.11M-$0.94-3.91 Is VVX or ABSI more profitable? V2X has a net margin of 1.63% compared to Absci's net margin of -2,737.94%. V2X's return on equity of 15.28% beat Absci's return on equity.Company Net Margins Return on Equity Return on Assets V2X1.63% 15.28% 5.01% Absci -2,737.94%-60.21%-50.85% SummaryV2X beats Absci on 10 of the 16 factors compared between the two stocks. Get Absci News Delivered to You Automatically Sign up to receive the latest news and ratings for ABSI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ABSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABSI vs. The Competition Export to ExcelMetricAbsciMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$599.59M$3.38B$6.11B$10.63BDividend YieldN/A2.29%5.67%4.71%P/E Ratio-3.9122.2585.9726.57Price / Sales121.46461.00612.03132.55Price / CashN/A47.2238.5062.09Price / Book2.3610.2112.756.53Net Income-$103.11M-$52.40M$3.31B$276.43M7 Day Performance8.88%0.86%0.80%-0.88%1 Month Performance34.31%10.39%6.21%3.55%1 Year Performance-9.58%27.24%80.34%37.91% Absci Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABSIAbsci3.0368 of 5 stars$3.68-8.2%$7.98+116.8%-2.9%$599.59M$4.53M-3.91210Analyst ForecastVVXV2X4.024 of 5 stars$60.36+1.2%$63.73+5.6%-6.2%$1.89B$4.32B27.4416,100Analyst ForecastLZLegalZoom.com2.8383 of 5 stars$10.08-1.6%$10.83+7.5%+48.0%$1.85B$681.88M63.001,220Analyst ForecastRAMPLiveRamp4.6942 of 5 stars$28.00+2.2%$40.83+45.8%+11.5%$1.80B$745.58M127.281,300News CoverageAnalyst ForecastALITAlight4.5638 of 5 stars$3.24-0.9%$8.75+170.1%-57.4%$1.76B$2.33B-1.479,500News CoverageAnalyst ForecastFIVNFive94.4659 of 5 stars$23.09+1.3%$37.88+64.1%-31.1%$1.76B$1.11B256.583,073Analyst ForecastOptions VolumeACVAACV AuctionsN/A$9.69-4.2%N/AN/A$1.74B$637.16M-24.852,900OLOOLO1.794 of 5 stars$10.26flat$10.17-0.9%N/A$1.74B$314.33M28.50710FLYWFlywire2.9663 of 5 stars$13.47-0.6%$13.54+0.5%-23.7%$1.66B$492.14M269.401,250Analyst ForecastASTHAstrana Health4.0062 of 5 stars$28.87+0.4%$50.50+74.9%-48.9%$1.61B$2.42B56.611,900News CoverageAnalyst ForecastGDRXGoodRx4.1113 of 5 stars$4.58+1.1%$5.80+26.6%-37.9%$1.57B$792.32M45.80950Trending NewsAnalyst Forecast Related Companies and Tools Related Companies V2X Competitors LegalZoom.com Competitors LiveRamp Competitors Alight Competitors Five9 Competitors ACV Auctions Competitors OLO Competitors Flywire Competitors Astrana Health Competitors GoodRx Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ABSI) was last updated on 10/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Absci Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Absci With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
